Ramez Al Khayyat, President of UCC Holding, shares how the company has grown into a global player, the mindset behind its ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached ...